Genetic Technologies Ltd. (GENE)

NASDAQ: GENE · IEX Real-Time Price · USD
1.96
-0.12 (-5.56%)
At close: Jan 21, 2022 4:00 PM
1.96
0.00 (0.26%)
After-hours:Jan 21, 2022 4:51 PM EST
Market Cap39.95M
Revenue (ttm)90,642
Net Income (ttm)-5.32M
Shares Out20.43M
EPS (ttm)-0.60
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume88,725
Open2.04
Previous Close2.07
Day's Range1.92 - 2.07
52-Week Range1.77 - 6.48
Beta1.08
Analystsn/a
Price Targetn/a
Earnings Daten/a

About GENE

Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the comp...

IndustryLife Sciences Tools & Services
Founded1989
Employees18
Stock ExchangeNASDAQ
Ticker SymbolGENE
Full Company Profile

Financial Performance

Financial numbers in millions AUDFinancial Statements

News

Genetic Technologies Reports Q2 FY22 Cash Flow Results

Q2 momentum sets the stage for a strong FY22 Q2 momentum sets the stage for a strong FY22

4 days ago - GlobeNewsWire

GENE Presents Study Involving 200,000 Participants at 2021 San Antonio Breast Cancer Symposium

MELBOURNE, Australia, Dec. 10, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious ...

1 month ago - GlobeNewsWire

Genetic Technologies Announces New Partnership and geneType COVID-19 Risk Test Patent Allowance from the USPTO

MELBOURNE, Australia, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious ...

1 month ago - GlobeNewsWire

Genetic Technologies Reports Q1 FY22 Results

Genetype MultiTest submitted for regulatory approval as commercialization plans gather momentum increase in cash receipts over prior quarter Genetype MultiTest submitted for regulatory approval as comme...

2 months ago - GlobeNewsWire

GENE Embarks on Breakthrough African American Collaboration for Breast Cancer as Part of Its Commitment to Ethnic Div...

Study to focus on women of African American descent for expanded polygenic risk test Study to focus on women of African American descent for expanded polygenic risk test

3 months ago - GlobeNewsWire

BelHealth Completes Asset Sale of General Genetics Corp.

FORT LAUDERDALE, Fla., Sept. 9, 2021 /PRNewswire/ -- September 9, 2021–BelHealth Investment Partners, LLC ("BelHealth") is pleased to announce that it has completed the sale of assets of the internation...

4 months ago - PRNewsWire

Genetic Technologies Reports FY21 Results as it Turns the Corner on its Commercialization Strategy

Company to present at H.C. Wainwright 23rd Annual Global Investment Conference taking place virtually September 13-15, 2021 Company to present at H.C. Wainwright 23rd Annual Global Investment Conference...

4 months ago - GlobeNewsWire

Genetic Technologies Rapidly Accelerating Commercialization Plans

MELBOURNE, Australia, July 26, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, “Company”, “GTG”), a global leader in Genomics based tests in health, wellness and serious disease, is...

5 months ago - GlobeNewsWire

Genetic Technologies Acquires EasyDNA To Expand Into Wellness Testing

Genetic Technologies Limited (NASDAQ: GENE) has agreed to acquire EasyDNA's brand and distribution rights from BelHealth for $4 million in cash and stock. EasyDNA currently sells paternity, oncology, an...

6 months ago - Benzinga

Genetic Technologies Strengthens Global Leadership in Genomics with Acquisition of EasyDNA

A global platform to market the Company's portfolio across 40 countries A global platform to market the Company's portfolio across 40 countries

6 months ago - GlobeNewsWire

Genetic Technologies Continues to Break New Ground as it Advances Development of its Predictive Risk Test for Multipl...

MELBOURNE, Australia, July 09, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG, NASDAQ: GENE, "Company", "GTG"), a diversified Genomics and AI driven preventative health business, today ...

6 months ago - GlobeNewsWire

US Patent Office Grants Foundational Pharmacogenomic Patent

MELBOURNE, Australia, June 11, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics and AI driven preventative health business, has be...

7 months ago - GlobeNewsWire

Infinity BiologiX, Genetic Technologies and Vault Heath launch new test to assess severity of COVID-19 in individuals

PISCATAWAY, N.J.--(BUSINESS WIRE)-- #covid19--Today, Infinity BiologiX (IBX) announces the launch of a new test meant to assess the severity of COVID-19 in individuals. The COVID-19 Risk Test is designe...

7 months ago - Business Wire

Genetic Technologies Interview to Air on Bloomberg Television U.S. on the RedChip Money Report®

MELBOURNE, Australia, May 13, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics and AI driven preventative health business, today a...

8 months ago - GlobeNewsWire

Genetic Technologies appoints Mike Tonroe as CFO

MELBOURNE, Australia, April 12, 2021 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”), announces the appointment of Michael Tonroe to th...

9 months ago - GlobeNewsWire

Genetic Technologies Provides Update on COVID-19 Risk Test Launch

MELBOURNE, Australia, April 09, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics and AI driven preventative health business provid...

9 months ago - GlobeNewsWire

Genetic Technologies Limited Interview to Air on Bloomberg TV in the US on the RedChip Money Report®

MELBOURNE, Australia, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today announc...

10 months ago - GlobeNewsWire

Genetic Technologies Announces Closing of $6.56 Million Registered Direct Offering

MELBOURNE, Australia, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today announc...

11 months ago - GlobeNewsWire

Why Addex, Genetic Technologies And Obalon Are Moving Today

Genetic Technologies (NASDAQ: GENE) shares are trading higher after the company provided an update on its COVID-19 severity risk test, saying predictive capabilities improved 100% over age and sex alone...

Other symbols:ADXN
1 year ago - Benzinga

Genetic Technologies Announces $6.56 Million Registered Direct Offering

MELBOURNE, Australia, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today announc...

1 year ago - GlobeNewsWire

GENE Stock Alert: 10 Things to Know About Genetic Technologies As Shares Rocket Higher

Shares of GENE stock are rising on Thursday morning after Genetic Technologies provided a positive update regarding two important initatives. The post GENE Stock Alert: 10 Things to Know About Genetic T...

1 year ago - InvestorPlace

Genetic Technologies Provides Update on its COVID-19 Disease Severity Risk Test and Expansion into Germline Testing

MELBOURNE, Australia, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”), provides the following update to the market on fur...

1 year ago - GlobeNewsWire

Genetic Technologies Interview Aired on Bloomberg International on the RedChip Money Report

MELBOURNE, Australia, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”) is pleased to announce an interview with its interi...

1 year ago - GlobeNewsWire

Genetic Technologies to Hold Investor Webinar and Q&A Session on November 19

MELBOURNE, Australia, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”) is pleased to announce its interim-CEO, Dr. Jerzy M...

1 year ago - GlobeNewsWire

Genetic Technologies Provides Update on COVID-19 Risk Test

MELBOURNE, Australia, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Ltd (ASX: GTG; NASDAQ: GENE, “Company”), provides the following update to the market on the dev...

1 year ago - GlobeNewsWire